202 related articles for article (PubMed ID: 30394930)
1. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
Perez PM; Hope TA; Behr SC; van Zante A; Small EJ; Flavell RR
Clin Nucl Med; 2019 Jan; 44(1):e28-e32. PubMed ID: 30394930
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
Shetty D; Loh H; Bui C; Mansberg R; Hadjashrafi A; Do V
Clin Nucl Med; 2016 Oct; 41(10):776-8. PubMed ID: 27556788
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT.
Lubin DJ; Holden SB; Rettig MB; Reiter RE; King CR; Lee JM; Wallace DW; Calais J
Clin Nucl Med; 2019 May; 44(5):e353-e356. PubMed ID: 30789399
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Acar E; Kaya GÇ
Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Jochumsen MR; Gormsen LC; Nielsen GL
Clin Nucl Med; 2018 Feb; 43(2):117-119. PubMed ID: 29261620
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
[TBL] [Abstract][Full Text] [Related]
8.
Damjanovic J; Janssen JC; Furth C; Diederichs G; Walter T; Amthauer H; Makowski MR
Cancer Imaging; 2018 May; 18(1):20. PubMed ID: 29769114
[TBL] [Abstract][Full Text] [Related]
9. Solitary PSMA-Positive Pulmonary Metastasis in Biochemical Relapse of Prostate Cancer.
Große Hokamp N; Kobe C; Linzenich E; Maintz D; Drzezga A
Clin Nucl Med; 2017 May; 42(5):406-407. PubMed ID: 28195907
[TBL] [Abstract][Full Text] [Related]
10. Uncommon Penio-Scrotal Metastases of Prostate Cancer Detected on 68Ga PSMA PET/CT.
Seniaray N; Verma R; Khanna S; Belho E; Malik D
Clin Nucl Med; 2019 May; 44(5):424-425. PubMed ID: 30829866
[TBL] [Abstract][Full Text] [Related]
11. Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer.
Snow HA; Hofman MS; Mitchell CA; Gyorki DE; Smith MJF
Clin Nucl Med; 2018 Jul; 43(7):509-511. PubMed ID: 29742609
[TBL] [Abstract][Full Text] [Related]
12. Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Arora S; Damle NA; Aggarwal S; Passah A; Behera A; Arora G; Bal C; Tripathi M
Clin Nucl Med; 2018 Jun; 43(6):449-451. PubMed ID: 29578871
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
[TBL] [Abstract][Full Text] [Related]
14. Prostate-Specific Membrane Antigen-Negative Metastases-A Potential Pitfall in Prostate-Specific Membrane Antigen PET.
Noto B; Auf der Springe K; Huss S; Allkemper T; Stegger L
Clin Nucl Med; 2018 Jun; 43(6):e186-e188. PubMed ID: 29659383
[TBL] [Abstract][Full Text] [Related]
15. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
Lin CY; Lee MT; Lin CL; Kao CH
Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999
[TBL] [Abstract][Full Text] [Related]
16. PSA levels, PSA doubling time, Gleason score and prior therapy cannot predict measured uptake of [68Ga]PSMA-HBED-CC lesion uptake in recurrent/metastatic prostate cancer.
Verburg FA; Pfister D; Drude NI; Mottaghy FM; Behrendt FF
Nuklearmedizin; 2017; 56(6):225-232. PubMed ID: 29044297
[TBL] [Abstract][Full Text] [Related]
17. Incidental Detection of Metastatic Malignant Melanoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT Imaging: Correlative Imaging With FDG PET/CT and Review of the Literature.
Anconina R; Hod N; Levin D; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2018 Mar; 43(3):204-206. PubMed ID: 29293137
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous uptake of
Hu Y; Wang P; Dai W
BMC Pulm Med; 2023 Mar; 23(1):73. PubMed ID: 36882747
[TBL] [Abstract][Full Text] [Related]
19. Multiphasic
Beheshti M; Manafi-Farid R; Geinitz H; Vali R; Loidl W; Mottaghy FM; Langsteger W
J Nucl Med; 2020 Oct; 61(10):1484-1490. PubMed ID: 32060214
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]